A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Genital Chlamydia trachomatis (Ct) infection induces protective immunity that depends on interferon-γ-producing CD4 T cells. By contrast, we report that mucosal exposure to ultraviolet light (UV)-inactivated Ct (UV-Ct) generated regulatory T cells that exacerbated subsequent Ct infection. We show that mucosal immunization with UV-Ct complexed with charge-switching synthetic adjuvant particles (cSAPs) elicited long-lived protection in conventional and humanized mice. UV-Ct-cSAP targeted immunogenic uterine CD11b(+)CD103(-) dendritic cells (DCs), whereas UV-Ct accumulated in tolerogenic CD11b(-)CD103(+) DCs. Regardless of vaccination route, UV-Ct-cSAP induced systemic memory T cells, but only mucosal vaccination induced effector T cells that rapidly seeded uterine mucosa with resident memory T cells (T(RM) cells). Optimal Ct clearance required both T(RM) seeding and subsequent infection-induced recruitment of circulating memory T cells. Thus, UV-Ct-cSAP vaccination generated two synergistic memory T cell subsets with distinct migratory properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“B and T cells, including Tregs and Th17 cells can, upon being primed by DCs presenting antigen derived from commensal organisms in draining mLNs of the gut, circulate systemically to facilitate immune responses at distant sites”
From The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy (2018) · cites this paper as Stary et al., 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1×
“For some experiments, we crossed NR1 and Foxp3eGFP mice (62).”
MethodTwo subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 1×
“This systemic memory population, which comprises the two classical central and effector memory subsets (59), does not appear to access the resting urogenital mucosa but can be recruited to peripheral tissues (including uterine mucosa) upon the onset of inflammation (60).”
BackgroundJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632 · cited 1×
“For characterization of uterine APC subsets, CXCR3 mice (63) were used.”
MethodT-Cell Function and Migration — Two Sides of the Same Coin
von Andrian, U. H., & Mackay, C. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431407 · Cited by 1,437 · cited 3×
“It is likely that additional trafficking molecules, such as chemokines, are involved in a tissue-specific multistep adhesion cascade for T cell recruitment to normal uterine mucosa (53), but the molecular identity of these constitutive traffic signals remains to be determined.”
BackgroundInfluentialSexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Su, J., Xu, F., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318286bb53 · Cited by 1,260
Gebhardt, T., Wakim, L. M., Eidsmo, L., Reading, P. C., Heath, W. R., & Carbone, F. R. (2009) · Nature Immunology · doi:10.1038/ni.1718 · Cited by 1,157 · cited 1×
“Acquisition of tissue tropism enables the preferential migration of Ag-experienced lymphocytes to regions of the body that are associated with the secondary lymphoid organs where Ag was first encountered (2, 3, 5-11).”
BackgroundSelective imprinting of gut-homing T cells by Peyer's patch dendritic cells
Mora, J. R., Bono, M. R., Manjunath, N., Weninger, W., Cavanagh, L. L., Rosemblatt, M., & von Andrian, U. H. (2003) · Nature · doi:10.1038/nature01726 · Cited by 1,074 · cited 3×
“Although systemic memory cells were elicited by all immunization routes, their protective capacity may vary due to differential imprinting of mucosal homing pathways during the priming phase (2-4, 54, 55).”
BackgroundGeneration of Gut-Homing IgA-Secreting B Cells by Intestinal Dendritic Cells
Mora, J. R., Iwata, M., Eksteen, B., Song, S.-Y., Junt, T., Senman, B., Otipoby, K. L., Yokota, A., Takeuchi, H., Ricciardi-Castagnoli, P., et al. (2006) · Science · doi:10.1126/science.1132742 · Cited by 1,011 · cited 1×
“, Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.”
BackgroundGoblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine
McDole, J. R., Wheeler, L. W., McDonald, K. G., Wang, B., Konjufca, V., Knoop, K. A., Newberry, R. D., & Miller, M. J. (2012) · Nature · doi:10.1038/nature10863 · Cited by 976
Physiological Migration of Hematopoietic Stem and Progenitor Cells
Wright, D. E., Wagers, A. J., Gulati, A. P., Johnson, F. L., & Weissman, I. L. (2001) · Science · doi:10.1126/science.1064081 · Cited by 933 · cited 1×
“Parabiosis surgery was performed as previously described (55).”
MethodRecent progress in mucosal vaccine development: potential and limitations
Lycke, N. (2012) · Nature Reviews Immunology · doi:10.1038/nri3251 · Cited by 807 · cited 1×
“However, only a handful of mucosal vaccines are currently available for use in humans, and most of these vaccines consist of replicating microorganisms, which may themselves cause infections in vulnerable individuals (17).”
BackgroundPipkin, M. E., Sacks, J. A., Cruz-Guilloty, F., Lichtenheld, M. G., Bevan, M. J., & Rao, A. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.012 · Cited by 795 · cited 1×
“Although systemic memory cells were elicited by all immunization routes, their protective capacity may vary due to differential imprinting of mucosal homing pathways during the priming phase (2-4, 54, 55).”
BackgroundResident memory CD8 T cells trigger protective innate and adaptive immune responses
Schenkel, J. M., Fraser, K. A., Beura, L. K., Pauken, K. E., Vezys, V., & Masopust, D. (2014) · Science · doi:10.1126/science.1254536 · Cited by 731
A vaccine strategy that protects against genital herpes by establishing local memory T cells
Shin, H., & Iwasaki, A. (2012) · Nature · doi:10.1038/nature11522 · Cited by 646 · cited 1×
“vaccines act in peripheral lymph nodes (LNs) to induce primarily skin-homing memory cells, mucosal vaccine exposure targets Ags into mucosa-associated lymphoid tissues (MALT) and focuses the ensuing memory response toward mucosal surfaces (6, 12-16).”
BackgroundSensing and alarm function of resident memory CD8+ T cells
Schenkel, J. M., Fraser, K. A., Vezys, V., & Masopust, D. (2013) · Nature Immunology · doi:10.1038/ni.2568 · Cited by 640
Sigmundsdottir, H., Pan, J., Debes, G. F., Alt, C., Habtezion, A., Soler, D., & Butcher, E. C. (2007) · Nature Immunology · doi:10.1038/ni1433 · Cited by 631 · cited 2×
“Although systemic memory cells were elicited by all immunization routes, their protective capacity may vary due to differential imprinting of mucosal homing pathways during the priming phase (2-4, 54, 55).”
BackgroundDynamic T cell migration program provides resident memory within intestinal epithelium
Masopust, D., Choo, D., Vezys, V., Wherry, E. J., Duraiswamy, J., Akondy, R., Wang, J., Casey, K. A., Barber, D. L., Kawamura, K. S., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090858 · Cited by 628 · cited 1×
“In an optimally immunized individual, Ct infection triggers rapid release of cytokines, particularly IFN-g, by the mucosal TRM subset, which promotes pathogen clearance (61).”
BackgroundImmunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine
Brunham, R. C., & Rey-Ladino, J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1551 · Cited by 617
Radovic-Moreno, A. F., Lu, T. K., Puscasu, V. A., Yoon, C. J., Langer, R., & Farokhzad, O. C. (2012) · ACS Nano · doi:10.1021/nn3008383 · Cited by 539 · cited 9×
“Using an emulsion-based manufacturing process, cSPs self-assemble from a tri-block co-polymer, poly(D,L-lactic-co-glycolic acid)b-poly(L-histidine)-bpoly(ethylene glycol) (PLGA-PLH-PEG) to form a hydrophobic core (PLGA) and a bilayered hydrophilic surface consisting of an inner layer of PLH and an outer layer of PEG (…”
BackgroundMethodInfluentialSelf-citationMigratory properties of naive, effector, and memory CD8(+) T cells
Weninger, W., Crowley, M. A., Manjunath, N., & von Andrian, U. H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.7.953 · Cited by 515 · cited 1×
“This systemic memory population, which comprises the two classical central and effector memory subsets (59), does not appear to access the resting urogenital mucosa but can be recruited to peripheral tissues (including uterine mucosa) upon the onset of inflammation (60).”
BackgroundCampbell, D. J., & Butcher, E. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011502 · Cited by 490
Mazzini, E., Massimiliano, L., Penna, G., & Rescigno, M. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.012 · Cited by 475
Guy-Grand, D., Griscelli, C., & Vassalli, P. (1978) · The Journal of experimental medicine · doi:10.1084/jem.148.6.1661 · Cited by 415 · cited 1×
“Acquisition of tissue tropism enables the preferential migration of Ag-experienced lymphocytes to regions of the body that are associated with the secondary lymphoid organs where Ag was first encountered (2, 3, 5-11).”
BackgroundMatteoli, G., Mazzini, E., Iliev, I. D., Mileti, E., Fallarino, F., Puccetti, P., Chieppa, M., & Rescigno, M. (2010) · Gut · doi:10.1136/gut.2009.185108 · Cited by 378
Mice lacking all conventional MHC class II genes
Madsen, L., Labrecque, N., Engberg, J., Dierich, A., Svejgaard, A., Benoist, C., Mathis, D., & Fugger, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10338 · Cited by 330 · cited 2×
“129S2-H2/J (referred to as MHC class II) (48), CD8, mMt, Il10, Rag2, and C57BL6 B6.”
BackgroundIntestinal CD103+ dendritic cells: master regulators of tolerance?
Scott, C. L., Aumeunier, A. M., & Mowat, A. M. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.003 · Cited by 321 · cited 1×
“duction of intestinal tolerance and immunity, respectively (49).”
BackgroundBrainard, D. M., Seung, E., Frahm, N., Cariappa, A., Bailey, C. C., Hart, W. K., Shin, H.-S., Brooks, S. F., Knight, H. L., Eichbaum, Q., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02207-08 · Cited by 288 · cited 2×
“BLT mice were generated in the MGH Humanized Mouse Program by transplanting irradiated NOD/SCID/gc mice with human fetal liver stem cells and autologous thymic grafts (57).”
BackgroundMethodSelf-citationBergsbaken, T., & Bevan, M. J. (2015) · Nature Immunology · doi:10.1038/ni.3108 · Cited by 274
Gallichan, W. S., & Rosenthal, K. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1879 · Cited by 238 · cited 1×
“vaccines act in peripheral lymph nodes (LNs) to induce primarily skin-homing memory cells, mucosal vaccine exposure targets Ags into mucosa-associated lymphoid tissues (MALT) and focuses the ensuing memory response toward mucosal surfaces (6, 12-16).”
BackgroundA Predominant Role for Antibody in Acquired Immunity to Chlamydial Genital Tract Reinfection
Morrison, S. G., & Morrison, R. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7536 · Cited by 222 · cited 1×
“TH1 cells are also a key component of long-term protective memory post infection, although a role for B cells and antibodies has also been reported (42-47).”
BackgroundBrunham, R. C., Kuo, C. C., Cles, L., & Holmes, K. K. (1983) · Infection and Immunity · doi:10.1128/iai.39.3.1491-1494.1983 · Cited by 188 · cited 1×
“TH1 cells are also a key component of long-term protective memory post infection, although a role for B cells and antibodies has also been reported (42-47).”
BackgroundIlyinskii, P. O., Roy, C. J., O’Neil, C. P., Browning, E. A., Pittet, L. A., Altreuter, D. H., Alexis, F., Tonti, E., Shi, J., Basto, P. A., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.02.027 · Cited by 171
Self-citationSantosuosso, M., Zhang, X., McCormick, S., Wang, J., Hitt, M., & Xing, Z. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7986 · Cited by 166 · cited 1×
“vaccines act in peripheral lymph nodes (LNs) to induce primarily skin-homing memory cells, mucosal vaccine exposure targets Ags into mucosa-associated lymphoid tissues (MALT) and focuses the ensuing memory response toward mucosal surfaces (6, 12-16).”
BackgroundGeisler, W. M., Lensing, S., Press, C. G., & Hook, E. W. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit094 · Cited by 163
Gondek, D. C., Olive, A. J., Stary, G., & Starnbach, M. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103032 · Cited by 152
Self-citationLee, H. K., Zamora, M., Linehan, M. M., Iijima, N., Gonzalez, D., Haberman, A., & Iwasaki, A. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20080601 · Cited by 149 · cited 1×
“vaccines act in peripheral lymph nodes (LNs) to induce primarily skin-homing memory cells, mucosal vaccine exposure targets Ags into mucosa-associated lymphoid tissues (MALT) and focuses the ensuing memory response toward mucosal surfaces (6, 12-16).”
BackgroundVaccines against mucosal infections
Holmgren, J. R., & Svennerholm, A. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.03.014 · Cited by 145 · cited 1×
“) vaccination can generate efficient systemic and cutaneous immunity against many pathogens, vaccination by these nonmucosal routes often induces little or no protection at mucosal surfaces (1).”
BackgroundProtective Immunity to Chlamydia trachomatis Genital Infection: Evidence from Human Studies
Batteiger, B. E., Xu, F., Johnson, R. E., & Rekart, M. L. (2010) · The Journal of Infectious Diseases · doi:10.1086/652400 · Cited by 141 · cited 1×
“Recent clinical evidence suggests that humans develop at least partially protective immunity upon clearance of genital Ct infection, whereby interferon (IFN)-γ production, presumably by T-helper 1 (TH1) cells, was inversely correlated with the risk for reinfection (34-36).”
BackgroundDefending the mucosa: adjuvant and carrier formulations for mucosal immunity
Lawson, L. B., Norton, E. B., & Clements, J. D. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.009 · Cited by 140 · cited 1×
“Such safety concerns could be avoided with nonreplicating vaccines, such as killed pathogens or inanimate Ags; however, mucosal exposure to noninfectious Ags is typically insufficient to elicit a protective immune response unless the Ags are combined with potent adjuvants that are often too toxic for use in humans (18…”
BackgroundFc Receptor–Mediated Antibody Regulation of T Cell Immunity against Intracellular Pathogens
Moore, T. T., Ekworomadu, C. O., Eko, F. O., Macmillan, L., Ramey, K., Ananaba, G. A., Patrickson, J., Nagappan, P. R., Lyn, D., Black, C. M., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/377134 · Cited by 134 · cited 1×
“TH1 cells are also a key component of long-term protective memory post infection, although a role for B cells and antibodies has also been reported (42-47).”
BackgroundFunctional and Phenotypic Characterization of the Humanized BLT Mouse Model
Wege, A. K., Melkus, M. W., Denton, P. W., Estes, J. D., & García, J. V. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-75647-7_10 · Cited by 133 · cited 1×
“immune system from two unrelated donors (58).”
Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis
Hu, V. H., Holland, M. J., & Burton, M. J. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002020 · Cited by 131 · cited 1×
“ectopic pregnancy (20–22), and infectious blindness worldwide (23).”
BackgroundKantele, A., Zivny, J., Häkkinen, M., Elson, C. O., & Mestecky, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5173 · Cited by 129
Cutting Edge: CD4+CD25+ Regulatory T Cells Impaired for Intestinal Homing Can Prevent Colitis
Denning, T. L., Kim, G., & Kronenberg, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7487 · Cited by 125 · cited 1×
“This is in line with observations in a murine colitis model, where tissue-homing of Treg was not required to prevent intestinal inflammation (58).”
ResultVaccination againstChlamydiaGenital Infection Utilizing the MurineC. muridarumModel
Farris, C. M., & Morrison, R. P. (2010) · Infection and Immunity · doi:10.1128/iai.00881-10 · Cited by 112 · cited 1×
“finitive, the available data are consistent with experiments in mice where bacterial clearance after genital Ct or Cm infection is known to require TH1 cells (31, 37, 38).”
Farris, C. M., Morrison, S. G., & Morrison, R. P. (2010) · Infection and Immunity · doi:10.1128/iai.00622-10 · Cited by 98
van Ginkel, F. W., Jackson, R. J., Yoshino, N., Hagiwara, Y., Metzger, D., Connell, T. D., Vu, H. L., Martin, M., Fujihashi, K., & McGhee, J. R. (2005) · Infection and Immunity · doi:10.1128/iai.73.10.6892-6902.2005 · Cited by 84 · cited 1×
“Such safety concerns could be avoided with nonreplicating vaccines, such as killed pathogens or inanimate Ags; however, mucosal exposure to noninfectious Ags is typically insufficient to elicit a protective immune response unless the Ags are combined with potent adjuvants that are often too toxic for use in humans (18…”
BackgroundBelland, R. J., Ojcius, D. M., & Byrne, G. I. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro931 · Cited by 84
Li, L., & McSorley, S. J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003707 · Cited by 79 · cited 1×
“TH1 cells are also a key component of long-term protective memory post infection, although a role for B cells and antibodies has also been reported (42-47).”
BackgroundTRACHOMA VACCINE STUDIES ON TAIWAN*
Grayston, J. T., WOOLRIDGE, R. L., & Wang, S. (1962) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1962.tb30558.x · Cited by 77 · cited 3×
“Clinical trials in the 1960's with inactivated elementary bodies (EBs), the infectious form of Ct (24), achieved partial early protection, but at later stages some vaccinated individuals experienced more severe symptoms upon ocular Ct exposure than placebo recipients (24-30).”
BackgroundResultOlive, A. J., Gondek, D. C., & Starnbach, M. N. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.58 · Cited by 75 · cited 1×
“1 M nonessential amino acids, and 1 mM sodium pyruvate, as described (41).”
MethodSelf-citationTrachoma vaccine field trials in The Gambia
Sowa, S., Sowa, J., Collier, L., & Blyth, W. A. (1969) · Epidemiology and Infection · doi:10.1017/s0022172400042157 · Cited by 69
Pre-injury polypharmacy as a predictor of outcomes in trauma patients
Stawicki, S. P., Evans, D., Gerlach, A. T., Christy, J. M., Jarvis, A., Lindsey, D., Whitmill, M., Eiferman, D. S., Murphy, C. V., Cook, C. H., et al. (2011) · International Journal of Critical Illness and Injury Science · doi:10.4103/2229-5151.84793 · Cited by 68 · cited 1×
“Although systemic memory cells were elicited by all immunization routes, their protective capacity may vary due to differential imprinting of mucosal homing pathways during the priming phase (2-4, 54, 55).”
BackgroundTowards a safe and effective chlamydial vaccine: Lessons from the eye
Mabey, D. C. W., Hu, V. H., Bailey, R. L., Burton, M. J., & Holland, M. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.10.016 · Cited by 66
Monitoring the T cell response to genital tract infection
Roan, N. R., Gierahn, T. M., Higgins, D. E., & Starnbach, M. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603866103 · Cited by 64
Self-citationWOOLRIDGE, R. L., Grayston, J. T., Chang, I. H., Cheng, K. H., Yang, C. Y., & Neave, C. (1967) · American Journal of Ophthalmology · doi:10.1016/0002-9394(67)94158-x · Cited by 55 · cited 3×
“Clinical trials in the 1960's with inactivated elementary bodies (EBs), the infectious form of Ct (24), achieved partial early protection, but at later stages some vaccinated individuals experienced more severe symptoms upon ocular Ct exposure than placebo recipients (24-30).”
BackgroundResultOverview of Chlamydia trachomatis Infection and the Requirements for a Vaccine
Schachter, J. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.6.713 · Cited by 52 · cited 1×
“Clinical trials in the 1960's with inactivated elementary bodies (EBs), the infectious form of Ct (24), achieved partial early protection, but at later stages some vaccinated individuals experienced more severe symptoms upon ocular Ct exposure than placebo recipients (24-30).”
BackgroundHawkins, R. A., Rank, R. G., & Kelly, K. A. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5587-5594.2000 · Cited by 50
Nichols, R. L., Bell, S. D., Murray, E. S., Haddad, N. A., & Bobb, A. A. (1966) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1966.15.639 · Cited by 48
Genetic analysis of susceptibility to Chlamydia trachomatis in mouse
Bernstein-Hanley, I., Balsara, Z. R., Ulmer, W., Coers, J., Starnbach, M. N., & Dietrich, W. F. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364285 · Cited by 46
Self-citationDavila, S. J., Olive, A. J., & Starnbach, M. N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303238 · Cited by 42
Self-citationThe mucosal immunologic network.
Bienenstock, J. (1984) · PubMed · Cited by 38
Chlamydia trachomatis and ectopic pregnancy: recent epidemiological findings
Bakken, I. J. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f3d972 · Cited by 27 · cited 1×
“Ct is the most common sexually transmitted bacterial pathogen and the leading cause of female infertility, ectopic pregnancy (20-22) and infectious blindness worldwide (23).”
BackgroundNichols, R. L., Bell, S. D., Haddad, N. A., & Bobb, A. A. (1969) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1969.18.723 · Cited by 22 · cited 3×
“Clinical trials in the 1960's with inactivated elementary bodies (EBs), the infectious form of Ct (24), achieved partial early protection, but at later stages some vaccinated individuals experienced more severe symptoms upon ocular Ct exposure than placebo recipients (24-30).”
BackgroundResultImmunity to Chlamydia trachomatis
Brunham, R. C. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit095 · Cited by 21 · cited 1×
“Recent clinical evidence suggests that humans develop at least partially protective immunity upon clearance of genital Ct infection, whereby interferon (IFN)-γ production, presumably by T-helper 1 (TH1) cells, was inversely correlated with the risk for reinfection (34-36).”
BackgroundNichols, R. L., Bell, S. D., Na, H., et al. (1969) · PubMed · Cited by 21
Tifrea, D. F., Ralli-Jain, P., Pal, S., & de la Maza, L. M. (2013) · Infection and Immunity · doi:10.1128/iai.00734-12 · Cited by 15 · cited 1×
“TH1 cells are also a key component of long-term protective memory post infection, although a role for B cells and antibodies has also been reported (42-47).”
Background
Cited by
The microbiota in adaptive immune homeostasis and disease
Honda, K., & Littman, D. R. (2016) · Nature · doi:10.1038/nature18848 · Cited by 1,846
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A., & Wargo, J. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.015 · Cited by 1,392
“…cells, can, upon being primed by DCs presenting antigen derived from commensal organisms in draining mLNs of the gut, circulate systemically to facilitate immune responses at distant sites against the same organism or against other antigens by crossreaction to similar epitopes (Stary et al., 2015).”
BackgroundTissue-resident memory T cells: local specialists in immune defence
Mueller, S. N., & Mackay, L. K. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.3 · Cited by 1,006
The multifaceted role of CD4+ T cells in CD8+ T cell memory
Laidlaw, B. J., Craft, J. E., & Kaech, S. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.10 · Cited by 657
Tissue-Resident T Cells and Other Resident Leukocytes
Masopust, D., & Soerens, A. G. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053214 · Cited by 608
“That said, local antigen recognition can have a pronounced influence on the differentiation of Trm cells, and in situ detection during the effector phase of the immune response promotes Trm cell accumulation in certain tissues including brain, skin, lung, and the female reproductive tract (37, 47, 90, 99, 101, 102).”
Background
Metadata
- Authors
- Stary, G., Olive, A., Radovic-Moreno, A. F., Gondek, D., Alvarez, D., Basto, P. A., Perro, M., Vrbanac, V. D., Tager, A. M., Shi, J., Yethon, J. A., Farokhzad, O. C., Langer, R., Starnbach, M. N., & von Andrian, U. H.
- Affiliations
- Harvard University (US)
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.
- Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA.
- Harvard–MIT Division of Health Sciences and Technology (US)
- Brigham and Women's Hospital (US)
- Sanofi Pasteur, Cambridge, MA 02139, USA.
- Corresponding author
- Stary, Georg
- Olive, Andrew
- ORCID
- Venue
- Science
- Published
- 2015-06-19
- Volume
- 348
- Issue
- 6241
- Pages
- aaa8205-aaa8205
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4605428
- OpenAlex
- W1581039134
- Cited by
- 379
- References
- 67
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 31 · 2023: 31 · 2022: 22 · 2021: 34 · 2020: 42 · 2019: 45 · 2018: 44 · 2017: 47 · 2016: 38 · 2015: 9
- FWCI
- 38.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- PMC
- Funders
- NIH (AI078897, AI069259, AI095261, AI111595, U54-CA119349, U54-CA151884, R37-EB000244, R01-EB015419-01, R00 CA160350, T32 HL066987, P30-AI060354, R01 AI062827, R01 AI39558, U19 AI113187)
- MGH
- MIT
- Harvard University
- arvard Innovation Award from Sanofi Pasteur
- David Koch Prostate Cancer Foundation
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- Chlamydia trachomatis, mucosal vaccines, regulatory T cells, tissue-resident memory T cells, genital tract infection, humanized mice, vaccine adjuvants
- MeSH terms
- Adjuvants, Immunologic, Animals, Bacterial Vaccines, Chlamydia Infections, Chlamydia trachomatis, Dendritic Cells, Female, Immunologic Memory, Mice, Inbred BALB C, Mice, Inbred C57BL, Mucous Membrane, Ultraviolet Rays, Uterus, Vaccination, Vaccines, Inactivated, Antigens, CD, T-Lymphocyte Subsets, CD8-Positive T-Lymphocytes, Th1 Cells, CD11 Antigens, Integrin alpha Chains, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.